Tag: David W. Goodman MD

05

Feb2009

Diagnosis of Adult ADHD

0  
The diagnosis of ADHD is best determined by a combination of a comprehensive history, adherence to well-described clinical criteria, and training in the differential diagnosis of adult disorders. Neuropsychiatric testing is beneficial for assessing learning disabilities, executive function, and other cognitive impairments, but it has not demonstrated value in the ... Read More
February 5, 2009David W. Goodman, MD

30

Jan2009

Effect of lisdexamfetamine dimesylate on sleep in adults with attention-deficit/hyperactivity disorder

0  
Adler L, Goodman DW, Weisler R, Hamdani M, Roth T. Effect of lisdexamfetamine dimesylate on sleep in adults with attention-deficit/hyperactivity disorder. Behavioral and Brain Functions 2009, 5:34
January 30, 2009David W. Goodman, MD

01

Jan2009

ADHD in Adults: Update for Clinicians on Diagnosis and Assessment.

0  
David W. Goodman, M.D. ADHD in Adults: Update for Clinicians on Diagnosis and Assessment. Primary Psychiatry. 2009;16(11):38-47
January 1, 2009David W. Goodman, MD

28

Dec2008

Specialists: Signs of ADHD in adults often misconstrued

0  
A study found that adults with ADHD on average miss more than three weeks per year in workplace productivity. Sacramento Bee Lunch rush was over, but distractions remained numerous inside the cafe just off a highway in Auburn, Calif. Blenders whirred out smoothies every few minutes, laughter erupted from a nearby group, ... Read More
December 28, 2008David W. Goodman, MD

30

Nov2008

Assessment and Diagnosis of Adult ADHD Clinical Challenges and Opportunities for Improving Patient Care.

0  
Weisler R, Goodman D, 2008. Assessment and Diagnosis of Adult ADHD Clinical Challenges and Opportunities for Improving Patient Care. Clinical Focus. Primary Psychiatry. November 2008
November 30, 2008David W. Goodman, MD

14

Sep2008

The moment of focus A diagnosis of ADHD at age 37 propelled Cass Brown Capel onto the path of therapy, medication — and fulfillment

0  
Lunch rush was over, but distractions remained numerous inside the La Bou cafe just off Highway 49 in Auburn. Blenders whirred out smoothies every few minutes, laughter erupted from a nearby group, a young worker noisily cleared tables. Yet, through it all, Cass Brown Capel stayed focused -- eyes locked on ... Read More
September 14, 2008David W. Goodman, MD

09

Sep2008

Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder.

0  
Lenard A. Adler, M.D.; David W. Goodman, M.D.; Scott H. Kollins, Ph.D.; Richard H. Weisler, M.D.; Suma Krishnan, M.S.; Yuxin Zhang, Ph.D.; and Joseph Biederman, M.D., on behalf of the 303 Study Group. Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder. Published ... Read More
September 9, 2008David W. Goodman, MD

04

Sep2008

Adult ADHD Therapy: Finding the Right Therapist

0  
For adults withADHD, the standard treatment is medication. But experts say that ADHD therapy -- and other psychosocial treatments -- can play a key role alongside drugs. “I think for many adults with ADHD, therapy is essential,” says David W. Goodman MD, assistant professor of psychiatry at the Johns Hopkins University School of Medicine. Recommended Related to ... Read More
September 4, 2008David W. Goodman, MD

04

Sep2008

Sharing a Diagnosis: When You and Your Child Have ADHD

0  
Your son or daughter was just diagnosed with ADHD, or attention deficit hyperactivity disorder. And as you sat there in the office, listening to the doctor tick off the symptoms – the attention problems, the disorganization, the fidgeting – you recognized yourself. Suddenly, you wonder: Could I have adult ADHD? You ... Read More
September 4, 2008David W. Goodman, MD

22

Jul2008

Celebrity Designer and ADHD Spokesperson Ty Pennington Partners With Shire to Announce the Launch of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults

0  
ATLANTA, July 22 /PRNewswire-FirstCall/ — Shire Limited , the global specialty biopharmaceutical company, today announced that it has launched VYVANSE(TM) (lisdexamfetamine dimesylate) for the treatment of adults with Attention Deficit Hyperactivity Disorder (ADHD). This launch follows the recent FDA approval of VYVANSE to treat ADHD in the adult population. VYVANSE ... Read More